Related Experiment Videos
Feasibility of sentinel lymph node detection in nodular thyroid disease
1The Department of Surgical Oncology, NCI, Cairo University, Egypt. habdallah@nci.edu.eg
Journal of the Egyptian National Cancer Institute
|January 24, 2007
Summary
Sentinel lymph node biopsy is technically feasible and safe for thyroid nodules. Further research is needed to refine its accuracy for routine thyroid cancer management.
Area of Science:
- Oncology
- Surgical Pathology
- Nuclear Medicine
Background:
- Sentinel lymph node biopsy (SLNB) is established for melanoma and breast cancer staging.
- Occult lymph node metastases are frequent in well-differentiated thyroid cancer (WDTC).
- Identifying nodal status in WDTC may guide therapeutic decisions.
Purpose of the Study:
- To evaluate the technical feasibility of SLNB in patients with uni-nodular thyroid disease.
- To assess the safety of SLNB in this specific patient population.
Main Methods:
- Prospective study of 30 patients with benign solitary thyroid nodules.
- Preoperative fine-needle aspiration cytology confirmed absence of palpable lymph nodes.
- Isosulfan blue vital dye injected into the nodule to trace lymphatic drainage.
Main Results:
- SLNB was performed in 30 patients; lymphatics observed in 23, sentinel nodes identified in 18 (60% detection rate).
- Nodes located in central (14) and lateral (3) compartments; some in both.
- No intraoperative or postoperative complications reported.
Conclusions:
- SLNB can be safely performed in the thyroid setting.
- The accuracy of SLNB for thyroid neoplasia requires further investigation in larger patient cohorts.
- The role of SLNB in routine thyroid cancer management is yet to be determined.